Vivani Medical, Inc. Marketable Securities, Gain (Loss)
Vivani Medical, Inc. (VANI) had Marketable Securities, Gain (Loss) of $500.00 thousand as of 2020-07-23, per its 10-Q filed 2020-11-12.
Discontinued › Notes › ASU 2016-13 Transition
us-gaap:MarketableSecuritiesGainLoss · last filed 2020-11-12
- 2020-07-23: Marketable Securities, Gain (Loss) $500.00K.
| Period end | Marketable Securities, Gain (Loss) |
|---|---|
| 2020-07-23 | $500.00K 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B |